Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Atherosclerosis Research

Background:

• High-density lipoprotein (HDL) possesses atheroprotective properties, including reverse cholesterol transport, antioxidant, anti-inflammatory, and endothelial cell maintenance functions.
• However, HDL functionality is not uniform; conditions like infection, inflammation, diabetes, and coronary artery disease are linked to dysfunctional HDL.
• Dysfunctional HDL arises from mechanisms such as altered protein composition, myeloperoxidase-mediated oxidative modification, and lipid alterations.

Purpose of the Study:

• To investigate the functional equivalence of HDL and the impact of disease states on its protective activities.
• To elucidate the mechanisms by which HDL loses its protective functions.
• To highlight the clinical relevance of assessing HDL functionality in cardiovascular disease.

Main Methods:

• Studies utilized bacterial endotoxin administration in human and mouse models.
• Analysis of HDL composition and cholesterol acceptor activity.
• Assessment of hepatic cholesterol processing and secretion.

Main Results:

• Bacterial endotoxin exposure induced significant changes in HDL composition.
• Dysfunctional HDL exhibited diminished cholesterol acceptor activity.
• Hepatic processing and secretion of cholesterol were decreased in the presence of dysfunctional HDL.

Conclusions:

• HDL functionality can be compromised by disease states, leading to loss of atheroprotective effects.
• Dysfunctional HDL plays a role in cardiovascular disease pathogenesis.
• A clinical assay for dysfunctional HDL is needed to assess its risk factor potential and evaluate drug therapies.